Interview: Kanchana TK – Director General, Organisation of Pharmaceutical…
Kanchana TK, director general of the Organisation of Pharmaceutical Producers of India (OPPI), the association…
Organisation of Pharmaceutical Producers of India (OPPI)
Last updated: 13.02.2014
Address: Peninsula Chambers, Ground Floor,
Ganpatrao Kadam Marg,
Lower Parel,
Mumbai 400 013.,India
Tel: +91 22 24918123
Web: http://www.indiaoppi.com/
Company description
The Organisation of Pharmaceutical Producers of India (OPPI) is an organisation of pharmaceutical manufacturers established in 1965.
Products and services
Its membership consists of Indian companies as well as companies with international collaboration. It represents primarily research based companies in India. The market share of its member firms in total pharmaceuticals market in India is around 60%. OPPI Members currently manufacture over 200 bulk drugs and account for 50% of the industry’s export of drugs and pharmaceuticals
Interviews
Interview with Tapan RAY, , Organisation of Pharmaceutical Producers of India…
Our last report on India dates back to 2006, right after the Patent Law was passed. What developments have you seen…
Related
India / 200% Pharma Sector Budget Boost; 3x Industry Growth in Next Decade; Pfizer Vaccine Rebuffed
The latest news from Indian pharma, including a 200 percent boost for the country’s pharmaceutical industry in…
India / Pharma Market to Grow by 12-14% Up to 2023
The USD 41 billion Indian pharma industry, the world’s third largest by volume and 13th largest by value, stands…
India / Six Companies at the Forefront of COVID-19 Vaccine Development
Six Indian pharma and biotech firms have joined the global race to develop a vaccine for COVID-19 with…
Supply Chain / Indian Pharma Manufacturing: Back in Business
COVID-19 restrictions have severely hampered multinational pharma companies who rely on India for generics and…
Indian Generics in the USA / Destined for More Success?
A recent IQVIA report highlights the increasing importance of Indian firms to the USA’s burgeoning generic…
Coronavirus / Indian Pharma Supply Chain Hit by Covid-19 Outbreak
The ongoing coronavirus outbreak and the subsequent shutdown of factories in China is having severe repercussions…
News Roundup / Indian Pharma: January 2020
Below is a selection of the top stories in Indian pharma from recent months, ranging from efforts to counter the…
India / Biocon's New Facility & Expansion in APAC
Biocon, the first Indian company to have a biosimilar drug approved in the US, is taking another step forward with…
Gujarat / The Home of Indian Pharma
The state of Gujarat proudly stands as India’s main pharmaceutical hub, accounting for over 33 percent of the…
Pharma Faces / Vivek Sharma, PPS
Unlike many of his pharma peers, Vivek Sharma worked in operations and finance for two decades before joining the…
China: Indian Pharma Firms Incoming
The pharmaceutical industries of China and India, historically focused on their large domestic markets and exports…
India Healthcare: “Modicare” Lives On
Aditya Bhattacharji is Healthcare Practice Head at Eurasia Group. In this article, he looks at India’s…
